In this episode we talk about this weeks FDA updates including approvals for Reyvow and Secuado, and new indications for Xarelto and Xofluza. We also provide recent updated guidelines for community-acquired pneumonia (CAP)

In this episode we talk about a new indication for Descovy, FDA approvals for Scenesse, Aklief, and Beovu, new dosage form for Fasenra, and a new biosimilar for Forteo

In this episode we go over expanded approval for another Hepatitis C medication, an added indication for a drug used in multiple myeloma, new indication for a common oral diabetes medication and a new approval for a drug thats been around for a while.

In this episode we discuss a novel new oral agent for type 2 diabetes, 2 HIV medications with added indications, a new vaccine for an old enemy, and an update from last week about NDMA found in ranitidine. We also talk with Dr. Kathy Bender about flu season and debunk some myths around the flu vaccine

In Episode 3 we go over updates from the FDA including a new indications for products used to treat asthma, and certain cancers, as well as a new product for IBS-C. We also continue our series on flu season, talking about who needs the vaccine and whats available.

In this Episode we go over FDA news from the week of September 8th, including an update in Hepatitis C products, a new treatment for hypoglycemia, and an added indication for a unique inflammatory condition. We'll also discuss the current flu season and what we can expect

In Episode 1, we discuss a new drug used to treat Parkinson's Disease symptoms, an explanation for the national immunoglobulin shortage, and an update to Clostridium difficile treatment - ENJOY!